Leber's Hereditary Optic Neuropathy - Pipeline Insight, 2018
SKU ID :DEL-11471818 | Published Date: 01-Jan-2018 | No. of pages: 50Description
TOC
1. Report Introduction
2. Leber's Hereditary Optic Neuropathy Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Leber's Hereditary Optic Neuropathy
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight
Tables & Figures
Table 1: Total Products for Leber's Hereditary Optic Neuropathy
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products
Figure 1: Total Products for Leber's Hereditary Optic Neuropathy
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products
Companies
Alkeus Pharmaceuticals Inc
Biovista Inc
GenSight Biologics SA
Ixchel Pharma LLC
Khondrion BV
Mitotech SA
Spark Therapeutics Inc
& list continues…
- PRICE
-
$1250$4000